<Table 1>
 <caption text="

   Main antimicrobial resistance genes found in Democratic Republic of the Congo.
  
">
 </caption>
 <row row="0">
  <cell col="0" row="0" text="Species">
  </cell>
  <cell col="1" row="0" text="Methods">
  </cell>
  <cell col="2" row="0" text="No. of strains">
  </cell>
  <cell col="3" row="0" text="Antibiotic resistance genes">
  </cell>
  <cell col="4" row="0" text="References">
  </cell>
 </row>
 <row row="1">
  <cell col="0" row="1" text="Salmonella
     
     spp
     
      .">
  </cell>
  <cell col="1" row="1" text="PCR, gene sequencing, whole-genome sequencing">
  </cell>
  <cell col="2" row="1" text="453">
  </cell>
  <cell col="3" row="1" text="bla
     

      CTX-M-15
     
     ,
     
      bla
     

      SHV-2a
     
     ,
     
      mph(A)
     
     ,
     
      gyrA
     
     mutation,
     
      qnrB1
     
     ,
     
      aac(6′)-Ib-cr
     
     ,
     
      bla
     

      TEM-1
     
     ,
     
      bla
     

      TEM-1b
     
     ,
     
      catA1
     
     ,
     
      strA/B
     
     ,
     
      sul1
     
     ,
     
      dfrA1
     
     ,
     
      aac(6′)-1aa">
  </cell>
  <cell col="4" row="1" text="[27,37,38,40,43,45,47,77]">
  </cell>
 </row>
 <row row="2">
  <cell col="0" row="2" text="Escherichia coli">
  </cell>
  <cell col="1" row="2" text="PCR, whole-genome sequencing">
  </cell>
  <cell col="2" row="2" text="21">
  </cell>
  <cell col="3" row="2" text="bla
     

      CTX-M-1
     
     ,
     
      bla
     

      TEM
     
     ,
     
      bla
     

      CMY
     
     ,
     
      bla
     

      OXA
     
     ,
     
      aac3
     
     ,
     
      ant2′′
     
     ,
     
      ant3′′
     
     ,
     
      aph3′′
     
     ,
     
      aph6
     
     ,
     
      pbp2
     
     ,
     
      aac6′
     
     ,
     
      qnrB
     
     ,
     
      mphA
     
     ,
     
      cat
     
     ,
     
      catA
     
     ,
     
      catB
     
     ,
     
      arr
     
     ,
     
      folp
     
     ,
     
      sulI
     
     ,
     
      sulII
     
     ,
     
      tetA
     
     ,
     
      tetB
     
     ,
     
      tetD
     
     ,
     
      dhfr">
  </cell>
  <cell col="4" row="2" text="[53,56]">
  </cell>
 </row>
 <row row="3">
  <cell col="0" row="3" text="Klebsiella
     
     spp
     
      .">
  </cell>
  <cell col="1" row="3" text="PCR">
  </cell>
  <cell col="2" row="3" text="3">
  </cell>
  <cell col="3" row="3" text="bla
     

      CTX-M-15
     
     ,
     
      bla
     

      SHV
     
     variants">
  </cell>
  <cell col="4" row="3" text="">
  </cell>
 </row>
 <row row="4">
  <cell col="0" row="4" text="Staphylococcus aureus">
  </cell>
  <cell col="1" row="4" text="PCR, whole-genome sequencing">
  </cell>
  <cell col="2" row="4" text="148">
  </cell>
  <cell col="3" row="4" text="aac(6′)-aph(2′′)
     
     ,
     
      tetK
     
     ,
     
      emrC
     
     ,
     
      mecA
     
     gene found, mutation in
     
      femA
     
     gene found,
     
      dfrG
     
     ,
     
      rpoB
     
     ,
     
      emrC">
  </cell>
  <cell col="4" row="4" text="[28,44]">
  </cell>
 </row>
 <row row="5">
  <cell col="0" row="5" text="">
  </cell>
  <cell col="1" row="5" text="">
  </cell>
  <cell col="2" row="5" text="">
  </cell>
  <cell col="3" row="5" text="">
  </cell>
  <cell col="4" row="5" text="">
  </cell>
 </row>
 <row row="6">
  <cell col="0" row="6" text="Vibrio cholerae">
  </cell>
  <cell col="1" row="6" text="Whole-genome sequencing">
  </cell>
  <cell col="2" row="6" text="78">
  </cell>
  <cell col="3" row="6" text="cardB
     
     ,
     
      intSXT
     
     ,
     
      sxt/R391
     
     ,
     
      sulII
     
     ,
     
      sulI
     
     ,
     
      qnrVC
     
     ,
     
      aph3-dprime
     
     ,
     
      aph6
     
     ,
     
      drfA
     
     ,
     
      dhfr
     
     ,
     
      flor
     
     ,
     
      gyrA
     
     (S83I),
     
      parC
     
     (S85L)">
  </cell>
  <cell col="4" row="6" text="">
  </cell>
 </row>
 <statements>
  <statement id="0" text="Klebsiella spp Species will have bla CTX-M-15 , bla SHV variants Antibiotic resistance genes." type="entailed">
  </statement>
  <statement id="1" text="Escherichia coli and Staphylococcus aureus Species will use same methods." type="entailed">
  </statement>
  <statement id="4" text="Many AMR genes were detected ( Table 1 )" type="entailed">
  </statement>
 </statements>
</Table 1>
<Table 2>
 <caption text="

   Prevalence of resistance among bacteria isolated in the Democratic Republic of the Congo.
  
">
 </caption>
 <row row="0">
  <cell col="0" row="0" text="Study period">
  </cell>
  <cell col="1" row="0" text="Microorganism isolated (year of isolation)">
  </cell>
  <cell col="2" row="0" text="Prevalence of resistance">
  </cell>
  <cell col="3" row="0" text="Gene identified">
  </cell>
  <cell col="4" row="0" text="References">
  </cell>
 </row>
 <row row="1">
  <cell col="0" row="1" text="1993">
  </cell>
  <cell col="1" row="1" text="Salmonella
     
     spp. (1986)">
  </cell>
  <cell col="2" row="1" text="90% (
     
      n
     

     =
     
     90) resistance to ampicillin, chloramphenicol, streptomycin, and tetracycline">
  </cell>
  <cell col="3" row="1" text="ND">
  </cell>
  <cell col="4" row="1" text="">
  </cell>
 </row>
 <row row="2">
  <cell col="0" row="2" text="2001">
  </cell>
  <cell col="1" row="2" text="Salmonella
     
     spp. and
     
      Escherichia coli
     
     (1990)">
  </cell>
  <cell col="2" row="2" text="100% resistance to ampicillin and chloramphenicol for
     
      Salmonella enteritidis
     
     , 65% (
     
      n
     

     =
     
     46) resistance to ampicillin and chloramphenicol for
     
      E. coli
     
     (
     
      n
     

     =
     
     19)">
  </cell>
  <cell col="3" row="2" text="ND">
  </cell>
  <cell col="4" row="2" text="">
  </cell>
 </row>
 <row row="3">
  <cell col="0" row="3" text="2009">
  </cell>
  <cell col="1" row="3" text="Salmonella
     
     Typhi (2005)">
  </cell>
  <cell col="2" row="3" text="All the strains (
     
      n
     

     =
     
     11) exhibited resistance to ampicillin (&gt;256
     
     mg/L) and cotrimoxazole (&gt;32
     
     mg/L)">
  </cell>
  <cell col="3" row="3" text="ND">
  </cell>
  <cell col="4" row="3" text="">
  </cell>
 </row>
 <row row="4">
  <cell col="0" row="4" text="2010">
  </cell>
  <cell col="1" row="4" text="Salmonella
     
     spp. (2006)">
  </cell>
  <cell col="2" row="4" text="For
     
      S. typhimurium
     
     , high proportion of isolates were resistant to ampicillin (85.7%), chloramphenicol (92.5%), and cotrimoxazole (94.7%). 6.1% of
     
      S. enteritidis
     
     tested were resistant to nalidixic acid and ciprofloxacin. 10.2% of
     
      S. enteritidis
     
     isolates were resistant to gentamicin. 89.7% of
     
      S
     
     . Typhi isolates presented a similar antimicrobial-resistant profile as the one observed among NTS">
  </cell>
  <cell col="3" row="4" text="Two isolates displayed resistance to cefoxitin (32 mg/L); the presence of the genes
     
      bla
     

      CMY-1
     
     ,
     
      bla
     

      CMY-2
     

      , bla
     

      ACC
     
     ,
     
      bla
     

      CTX-M
     
     , and
     
      bla
     

      TEM
     
     was negative">
  </cell>
  <cell col="4" row="4" text="">
  </cell>
 </row>
 <row row="5">
  <cell col="0" row="5" text="2013">
  </cell>
  <cell col="1" row="5" text="Salmonella typhimirium
     
     (2006)">
  </cell>
  <cell col="2" row="5" text="100% (
     
      n
     

     =
     
     11) resistance to ampicillin, cotrimoxazole, and chloramphenicol">
  </cell>
  <cell col="3" row="5" text="bla
     

      TEM-1b
     
     ,
     
      catA1
     
     ,
     
      strA/B
     
     ,
     
      sul1
     
     ,
     
      dfrA1
     
     ,
     
      aac(6′)-1aa">
  </cell>
  <cell col="4" row="5" text="">
  </cell>
 </row>
 <row row="6">
  <cell col="0" row="6" text="2014">
  </cell>
  <cell col="1" row="6" text="Salmonella
     
     spp. (2011)">
  </cell>
  <cell col="2" row="6" text="96% (
     
      n
     

     =
     
     180) resistance to ampicillin, chloramphenicol, and cotrimoxazole">
  </cell>
  <cell col="3" row="6" text="bla
     

      SHV-2a
     
     ,
     
      mph(A)">
  </cell>
  <cell col="4" row="6" text="">
  </cell>
 </row>
 <row row="7">
  <cell col="0" row="7" text="2014">
  </cell>
  <cell col="1" row="7" text="Salmonella
     
     spp. (2012)">
  </cell>
  <cell col="2" row="7" text="72.2% (
     
      n
     

     =
     
     18) of
     
      S.
     
     Typhi isolates showed co-resistance to ampicillin and cotrimoxazole, 33.3% showed additional resistance to chloramphenicol and hence were MDR. 97.6% (
     
      n
     

     =
     
     85) of NTS isolates were MDR; 1.0%
     
      S. typhimurium
     
     isolates had additional DCS">
  </cell>
  <cell col="3" row="7" text="gyrA
     
     gene mutation found">
  </cell>
  <cell col="4" row="7" text="">
  </cell>
 </row>
 <row row="8">
  <cell col="0" row="8" text="2015">
  </cell>
  <cell col="1" row="8" text="Salmonella
     
     spp. (2014)">
  </cell>
  <cell col="2" row="8" text="For
     
      S.
     
     Typhi isolates (
     
      n
     

     =
     
     164), MDR and DCS rates were 37.8% and 37.2%, respectively.
     
     MDR were 90.2% and 79.7%, respectively for
     
      S. typhimurium
     
     (386) and
     
      S. enteritidis
     
     (390). ESBL production was observed in 12.7% of
     
      S. typhimurium
     
     isolates">
  </cell>
  <cell col="3" row="8" text="gyrA
     
     mutation found,
     
      qnrB1
     
     ,
     
      aac(6′)-Ib-cr
     
     ,
     
      bla
     

      TEM-1">
  </cell>
  <cell col="4" row="8" text="">
  </cell>
 </row>
 <row row="9">
  <cell col="0" row="9" text="2017">
  </cell>
  <cell col="1" row="9" text="Salmonella
     
     Typhi (2015)">
  </cell>
  <cell col="2" row="9" text="Production of ESBL in
     
      S.
     
     Typhi was confirmed by PCR for the first time in DRC. The isolate further showed decreased susceptibility to ciprofloxacin, to pefloxacin and to nalidixic acid.">
  </cell>
  <cell col="3" row="9" text="bla
     

      CTX-M-15">
  </cell>
  <cell col="4" row="9" text="">
  </cell>
 </row>
 <row row="10">
  <cell col="0" row="10" text="2018">
  </cell>
  <cell col="1" row="10" text="Salmonella
     
     Typhi (2017)">
  </cell>
  <cell col="2" row="10" text="ESBL-producing
     
      S.
     
     Typhi isolate with a decreased ciprofloxacin susceptibility">
  </cell>
  <cell col="3" row="10" text="bla
     

      CTX-M-15">
  </cell>
  <cell col="4" row="10" text="">
  </cell>
 </row>
 <row row="11">
  <cell col="0" row="11" text="2018">
  </cell>
  <cell col="1" row="11" text="Salmonella
     
     spp. (2014)">
  </cell>
  <cell col="2" row="11" text="27% (
     
      n
     

     =
     
     60) resistance to cefuroxime, 20% to ceftriaxone and norfloxacin">
  </cell>
  <cell col="3" row="11" text="ND">
  </cell>
  <cell col="4" row="11" text="">
  </cell>
 </row>
 <row row="12">
  <cell col="0" row="12" text="2019">
  </cell>
  <cell col="1" row="12" text="Salmonella typhimurium
     
     (2016)">
  </cell>
  <cell col="2" row="12" text="67% (54/81) were ESBL producers and 63% were MDR (resistance to ampicillin, chloramphenicol, and cotrimoxazole).">
  </cell>
  <cell col="3" row="12" text="catA
     
     ,
     
      bla
     

      TEM-1
     
     ,
     
      dfrA
     
     ,
     
      dfrA1
     
     ,
     
      dfrA14
     
     ,
     
      bla
     

      SHV-2A
     
     ,
     
      mphA
     
     ,
     
      gyrA
     
     mutation (S83Y)">
  </cell>
  <cell col="4" row="12" text="">
  </cell>
 </row>
 <row row="13">
  <cell col="0" row="13" text="2019">
  </cell>
  <cell col="1" row="13" text="Salmonella
     
     Typhi (2017)">
  </cell>
  <cell col="2" row="13" text="38.4% (114/295) were resistant to ampicillin, chloramphenicol, and cotrimoxazole; 24.5% (73/295) had decreased sensitivity to ciprofloxacin">
  </cell>
  <cell col="3" row="13" text="gyrA
     
     (S83E, S83Y, D87Y, D87G, A119E),
     
      gyrB
     
     (E466D, S464Y)">
  </cell>
  <cell col="4" row="13" text="">
  </cell>
 </row>
 <row row="14">
  <cell col="0" row="14" text="2012">
  </cell>
  <cell col="1" row="14" text="Enterobacteriaceae (2011)">
  </cell>
  <cell col="2" row="14" text="7.4% (
     
      n
     

     =
     
     190) ESBL-producing Enterobacteriaceae">
  </cell>
  <cell col="3" row="14" text="bla
     

      CTX-M-1
     
     group">
  </cell>
  <cell col="4" row="14" text="">
  </cell>
 </row>
 <row row="15">
  <cell col="0" row="15" text="2014">
  </cell>
  <cell col="1" row="15" text="Enterobacteriaceae and non-fermenting Gram-negative rods (2013)">
  </cell>
  <cell col="2" row="15" text="16.3% (
     
      n
     

     =
     
     643) of isolates displayed an MDR phenotype; 80% (
     
      n
     

     =
     
     25) of isolates were ESBL producers">
  </cell>
  <cell col="3" row="15" text="bla
     

      CTX-M-1
     
     group">
  </cell>
  <cell col="4" row="15" text="">
  </cell>
 </row>
 <row row="16">
  <cell col="0" row="16" text="2014">
  </cell>
  <cell col="1" row="16" text="Enterobacteriaceae (2013)">
  </cell>
  <cell col="2" row="16" text="100% (
     
      n
     

     =
     
     79) resistance to tetracycline, over 90% resistance to ampicillin, cotrimoxazole, and chloramphenicol and over 65% resistance to norfloxacin">
  </cell>
  <cell col="3" row="16" text="ND">
  </cell>
  <cell col="4" row="16" text="">
  </cell>
 </row>
 <row row="17">
  <cell col="0" row="17" text="2015">
  </cell>
  <cell col="1" row="17" text="Enterobacteriaceae (2014)">
  </cell>
  <cell col="2" row="17" text="100% (
     
      n
     

     =
     
     112) resistance to cotrimoxazole, 67–100% resistance to ampicillin and &gt;50% of them were ESBL producers">
  </cell>
  <cell col="3" row="17" text="ND">
  </cell>
  <cell col="4" row="17" text="">
  </cell>
 </row>
 <row row="18">
  <cell col="0" row="18" text="2015">
  </cell>
  <cell col="1" row="18" text="Enterobacteriaceae and Gram-positive cocci (2015)">
  </cell>
  <cell col="2" row="18" text="98% (
     
      n
     

     =
     
     38) of
     
      E. coli
     
     and 65% (
     
      n
     

     =
     
     22) of
     
      S. aureus
     
     resistant to penicillin, and 92% of
     
      E. coli
     
     and 73% of
     
      S. aureus
     
     resistant to cefotaxime">
  </cell>
  <cell col="3" row="18" text="ND">
  </cell>
  <cell col="4" row="18" text="">
  </cell>
 </row>
 <row row="19">
  <cell col="0" row="19" text="2012">
  </cell>
  <cell col="1" row="19" text="Klebsiella
     
     spp
     
      .
     
     and
     
      Enterobacter aerogenes
     
     (2010)">
  </cell>
  <cell col="2" row="19" text="5.3% (150) of ESBL producers (eight isolates).">
  </cell>
  <cell col="3" row="19" text="Five
     
      bla
     

      CTX-M
     
     genes and three
     
      bla
     

      SHV
     
     variants">
  </cell>
  <cell col="4" row="19" text="">
  </cell>
 </row>
 <row row="20">
  <cell col="0" row="20" text="2019">
  </cell>
  <cell col="1" row="20" text="Escherichia coli
     
     (2014)">
  </cell>
  <cell col="2" row="20" text="All isolates were MDR, corresponding to ESBL producers (
     
      n
     

     =
     
     21). Twenty-one (21/21) and 19/21 strains were susceptible to imipenem and amikacin, respectively">
  </cell>
  <cell col="3" row="20" text="bla
     

      CTX-M-1
     
     ,
     
      bla
     

      TEM
     
     ,
     
      bla
     

      CMY
     
     ,
     
      bla
     

      OXA
     
     ,
     
      aac3
     
     ,
     
      ant2′′
     
     ,
     
      ant3′′
     
     ,
     
      aph3′′
     
     ,
     
      aph6
     
     ,
     
      pbp2
     
     ,
     
      aac6′, qnrB, mphA
     
     ,
     
      cat
     
     ,
     
      catA, catB
     
     ,
     
      arr
     
     ,
     
      folP
     
     ,
     
      sulI
     
     ,
     
      sulII
     
     ,
     
      tetA
     
     ,
     
      tetB
     
     ,
     
      tetD
     
     ,
     
      dhfr">
  </cell>
  <cell col="4" row="20" text="">
  </cell>
 </row>
 <row row="21">
  <cell col="0" row="21" text="2014">
  </cell>
  <cell col="1" row="21" text="Staphylococcus
     
     spp
     
      .
     
     (2013)">
  </cell>
  <cell col="2" row="21" text="63.5% (
     
      n
     

     =
     
     74) of
     
      S. aureus
     
     and 90% (
     
      n
     

     =
     
     15) of CNS were MRSA and MR-CNS, respectively">
  </cell>
  <cell col="3" row="21" text="ND">
  </cell>
  <cell col="4" row="21" text="">
  </cell>
 </row>
 <row row="22">
  <cell col="0" row="22" text="2015">
  </cell>
  <cell col="1" row="22" text="Staphylococcus aureus
     
     (2011)">
  </cell>
  <cell col="2" row="22" text="16% (
     
      n
     

     =
     
     63) were MRSA">
  </cell>
  <cell col="3" row="22" text="ND">
  </cell>
  <cell col="4" row="22" text="">
  </cell>
 </row>
 <row row="23">
  <cell col="0" row="23" text="2016">
  </cell>
  <cell col="1" row="23" text="Staphylococcus aureus
     
     (2014)">
  </cell>
  <cell col="2" row="23" text="33% (
     
      n
     

     =
     
     100) were MRSA, 72% resistance to cyclins and 54% resistance to cotrimoxazole">
  </cell>
  <cell col="3" row="23" text="mecA
     
     , mutation in
     
      femA
     
     gene found,
     
      dfrG
     
     ,
     
      rpoB
     
     ,
     
      emrC">
  </cell>
  <cell col="4" row="23" text="">
  </cell>
 </row>
 <row row="24">
  <cell col="0" row="24" text="2017">
  </cell>
  <cell col="1" row="24" text="Staphylococcus aureus
     
     (2016)">
  </cell>
  <cell col="2" row="24" text="36% (
     
      n
     

     =
     
     45) of isolates were MRSA">
  </cell>
  <cell col="3" row="24" text="ND">
  </cell>
  <cell col="4" row="24" text="">
  </cell>
 </row>
 <row row="25">
  <cell col="0" row="25" text="2017">
  </cell>
  <cell col="1" row="25" text="Staphylococcus aureus
     
     (2013)">
  </cell>
  <cell col="2" row="25" text="25% (
     
      n
     

     =
     
     108) were MRSA, 31% were resistant to aminoglycosides, 26% to macrolides, and 20% to ciprofloxacin">
  </cell>
  <cell col="3" row="25" text="aac(6′)-aph(2′′)
     
     ,
     
      tetK
     
     ,
     
      emrC">
  </cell>
  <cell col="4" row="25" text="">
  </cell>
 </row>
 <row row="26">
  <cell col="0" row="26" text="2015">
  </cell>
  <cell col="1" row="26" text="Vibrio cholerae
     
     (2013)">
  </cell>
  <cell col="2" row="26" text="98% (
     
      n
     

     =
     
     36) resistance to cotrimoxazole, 71% to nitrofurantoin, and 18% to nalidixic acid.">
  </cell>
  <cell col="3" row="26" text="ND">
  </cell>
  <cell col="4" row="26" text="">
  </cell>
 </row>
 <row row="27">
  <cell col="0" row="27" text="2015">
  </cell>
  <cell col="1" row="27" text="Vibrio cholerae
     
     (2012)">
  </cell>
  <cell col="2" row="27" text="Although sensitivity to fluoroquinolones seemed to be preserved, strain resistance patterns continued to evolve with the circulation of isolates resistant to tetracyclines and ampicillin from 2007 to 2010, and displayed a single antimicrobial drug susceptibility profile: resistance to most antimicrobial drugs (chloramphenicol, erythromycin, cotrimoxazole) except cyclins and fluoroquinolones.">
  </cell>
  <cell col="3" row="27" text="MLVA genotyping, no resistance genes searched">
  </cell>
  <cell col="4" row="27" text="">
  </cell>
 </row>
 <row row="28">
  <cell col="0" row="28" text="2019">
  </cell>
  <cell col="1" row="28" text="Vibrio cholerae
     
     (2017)">
  </cell>
  <cell col="2" row="28" text="100% (
     
      n
     

     =
     
     78) resistance and nalidixic acid, 12% and 14% resistance to ciprofloxacin and ampicillin, respectively">
  </cell>
  <cell col="3" row="28" text="cardB
     
     ,
     
      IntSXT
     
     ,
     
      sxt/R391
     
     ,
     
      sulII
     
     ,
     
      sulI
     
     ,
     
      qnrVC
     
     ,
     
      aph3-dprime
     
     ,
     
      aph6
     
     ,
     
      drfA
     
     ,
     
      dhfr
     
     ,
     
      flor
     
     ,
     
      gyr
     
     A (S83I),
     
      parC
     
     (S85L)">
  </cell>
  <cell col="4" row="28" text="">
  </cell>
 </row>
 <row row="29">
  <cell col="0" row="29" text="2016">
  </cell>
  <cell col="1" row="29" text="Streptococcus pneumoniae and Haemophilus influenzae
     
     (2014)">
  </cell>
  <cell col="2" row="29" text="83% (
     
      n
     

     =
     
     23) of
     
      S. pneumoniae
     
     isolates were resistant to penicillin, 28% (
     
      n
     

     =
     
     23) of
     
      H. influenzae
     
     were resistant to amoxicillin–clavulanic acid">
  </cell>
  <cell col="3" row="29" text="ND">
  </cell>
  <cell col="4" row="29" text="">
  </cell>
 </row>
 <row row="30">
  <cell col="0" row="30" text="2018">
  </cell>
  <cell col="1" row="30" text="Streptococcus pneumoniae
     
     (2015)">
  </cell>
  <cell col="2" row="30" text="70of the 163 isolates (43%) of the pneumococci were MDR (non-susceptible to ≥3 classes of antimicrobial agents, including β-lactams).">
  </cell>
  <cell col="3" row="30" text="ND (PCR done for serotyping only)">
  </cell>
  <cell col="4" row="30" text="">
  </cell>
 </row>
 <statements>
  <statement id="0" text="Study period 1993 of Microorganism isolated (year of isolation) is Salmonella spp. (1986) ." type="entailed">
  </statement>
  <statement id="1" text="Study period 2001 of Microorganism isolated (year of isolation) is Salmonella spp. and Escherichia coli (1990)." type="entailed">
  </statement>
  <statement id="2" text="Study period 2010 of Microorganism isolated (year of isolation) is Salmonella spp. (2006)." type="entailed">
  </statement>
  <statement id="3" text="The reference for study is same." type="refuted">
  </statement>
  <statement id="4" text="90% ( n = 90) resistance to ampicillin, chloramphenicol, streptomycin, and tetracycline Prevalence of resistance in study of 2200." type="refuted">
  </statement>
  <statement id="5" text="100% resistance to ampicillin and chloramphenicol for Salmonella enteritidis , 65% ( n = 46) resistance to ampicillin and chloramphenicol for E. coli ( n = 19) Prevalence of resistance in study of 2010." type="refuted">
  </statement>
  <statement id="6" text="Serotyping had not been completed, but it would give us valuable information about circulating strains with regard to the vaccine used." type="entailed">
  </statement>
 </statements>
</Table 2>